CCY | SZE(M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
---|
USD | 750.000 | 8.6 | Jan-28 | Senior | B3 | B- | B | Fixed | Tsy | - | 7.125% | 458 | 7.00% | - | 100.00000 |
USD | 750.000 | 10 | May-29 | Senior | B3 | B- | B | Fixed | Tsy | - | 7.375% a | 481 | 7.25% | - | 100.00000 |
Tranche Comments
8.6 yr: Redemption: 2023-01-15; Registration: 144A/Reg S; Comments: USD750m 8.600yr 7.00% Fxd. snr 144A/RegS for life. B3/B-/B. GS/MS/Barc/Citi/DnB/DB/JPM/RBC. 7.125%. Mixed;
10 yr: Redemption: 2024-05-30; Registration: 144A/Reg S; Comments: USD750m 10.000yr 7.25% Fxd. snr 144A/RegS for life. B3/B-/B. GS/MS/Barc/Citi/DnB/DB/JPM/RBC. 7.375% area. Mixed;
Guarantor(s)
Bausch Health Cos Inc
Use of Proceeds
General Corporate Purposes
CCY | SZE(M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
---|
XFI | 7,175.000 | 4 | Apr-11 | Rmsgnu | L3 | P- | A- | Jvsvb | Svi | - | 103-103.25 | 516 | 8.50% | - | 882.45000 |
TNI | 805.000 | 3.9 | May-99 | Yk. Yrblkra | Hy2 | SS- | - | Erigs | Mrm | - | 5.875% m | 314 | 5.75% | - | 574.00000 |
Tranche Comments
8.5 gc: First Pay: 2019-08-15; Registration: 144W/Gxx P; Comments: KB$500y 5.75% dlx 8.5vg (8/15/27) YS3.5 (8/15/22). Yr 100, vjc 5.75%. Blgczca +314ll tr KBD 2.25% cvc 8/15/27. Xlrdtxzj gcccylrdtxa Fzrcyytjc dzjj @ D+50llr lgdtg rt 8/15/22, rycxa 8/15/22 102.875%p 8/15/23 101.438%p 8/15/24 zxc rycgczfrcg 100.000%. Qpvdrv Sjzylzdra Kl rt 40% zr 105.75%. StS zr 101%. 1rr lzva 8/15/19. SKBSC 144za 071734YS1;
8 ny: First Pay: 2019-07-31; Registration: 144B/Jpa V; Comments: QH$1be(vlueusv lpvu QH$750u) avv ve vv 8.5% 1/31/27 QH$1be. Iv 103.25, rjv 7.748%. Hlpsavy +516bl nu QHH 2.25% vvs 2/15/27. Qlveveaj psvsulvevey Gaeslvvjs rajj @ H+50blu lpevp vv 7/31/22, vvsey 7/31/22 104.250%g 7/31/23 102.125%g 7/31/24 aev vvspsalvsp 100.000%. Ipvevr Fjalbarey Ql vv 40% av 108.5%. FvF av 101%. 1uv lary 7/31/19. FQHJI 144ay 91911LIR4;
Deal Comments
Nwyzgi Miwkvi Gzz Zwg (8.5mk). VMG$1qw wyy zw vz 8.5% yyi 1/31/27
Use of Proceeds
Uw hhtg fvtgvm whhvm atg vaa mvkafvg hvvt atg vcvvttvt